B cell alterations during BAFF inhibition with belimumab in SLEResearch in context

MLA

Daniel Ramsköld, et al. “B Cell Alterations during BAFF Inhibition with Belimumab in SLEResearch in Context.” EBioMedicine, vol. 40, no. 517–527, Feb. 2019, pp. 517–27. EBSCOhost, https://doi.org/10.1016/j.ebiom.2018.12.035.

APA

Daniel Ramsköld, Ioannis Parodis, Tadepally Lakshmikanth, Natalie Sippl, Mohsen Khademi, Yang Chen, Agneta Zickert, Jaromír Mikeš, Adnane Achour, Khaled Amara, Fredrik Piehl, Petter Brodin, Iva Gunnarsson, & Vivianne Malmström. (2019). B cell alterations during BAFF inhibition with belimumab in SLEResearch in context. EBioMedicine, 40(517–527), 517–527. https://doi.org/10.1016/j.ebiom.2018.12.035

Chicago

Daniel Ramsköld, Ioannis Parodis, Tadepally Lakshmikanth, Natalie Sippl, Mohsen Khademi, Yang Chen, Agneta Zickert, et al. 2019. “B Cell Alterations during BAFF Inhibition with Belimumab in SLEResearch in Context.” EBioMedicine 40 (517–527): 517–27. doi:10.1016/j.ebiom.2018.12.035.